2026-01-02 - Analysis Report
Okay, let's break down the analysis of Honeywell International Inc. (HON).

**Company Overview (1 line):** Honeywell International Inc. is a diversified technology and manufacturing company serving customers worldwide with aerospace products and services, building technologies, performance materials and technologies, and safety and productivity solutions.

**1) Return Rate Comparison and Divergence:**

*   **HON Cumulative Return:** 10.31%
*   **VOO (S&P 500) Cumulative Return:** 105.07%
*   **Divergence:** -94.76 (Current).  This means HON has significantly underperformed the S&P 500 over the period.
*   **Relative Divergence:** 2.5. This indicates that HON's current divergence from the S&P 500 is near its worst level compared to its historical divergence range.

**Alpha, Beta Analysis:**

| Year       | CAGR  | MDD   | Alpha | Beta | Cap(B) |
|------------|-------|-------|-------|------|--------|
| 2016-2018  | 34.0% | 71.0% | 5.0%  | 0.9  | 83.9   |
| 2017-2019  | 56.0% | 71.0% | 15.0% | 1.0  | 112.4  |
| 2018-2020  | 39.0% | 80.2% | 6.0%  | 1.1  | 135.1  |
| 2019-2021  | 45.0% | 80.2% | -31.0% | 1.1  | 132.4  |
| 2020-2022  | 24.0% | 83.1% | 5.0%  | 1.0  | 136.1  |
| 2021-2023  | 7.0%  | 83.1% | -21.0% | 0.8  | 133.2  |
| 2022-2024  | 10.0% | 82.7% | -20.0% | 0.8  | 143.5  |
| 2023-2025  | -1.0% | 79.8% | -69.0% | 0.8  | 131.5  |

*   **CAGR (Compound Annual Growth Rate):**  CAGR has declined significantly in recent periods.
*   **MDD (Maximum Drawdown):**  High MDD figures suggest significant price volatility and potential for losses. The MDD has been consistently high, staying above 70%.
*   **Alpha:**  Alpha is a measure of outperformance relative to a benchmark (likely the S&P 500). The trend is concerning, with Alpha becoming strongly negative in recent periods, indicating significant underperformance.
*   **Beta:**  Beta indicates the stock's volatility relative to the market.  A Beta around 1 suggests Honeywell's price generally moves in line with the market, while Beta of 0.8 shows the stock is less volatile than the market.
*   **Cap(B) (Market Capitalization in Billions):** Fluctuating around the 130-140B mark.

**2) Recent Stock Price Fluctuations:**

*   **Current Close:** 195.09
*   **Previous Close:** 196.36
*   **Change:** -0.65
*   **5-day SMA:** 196.57
*   **20-day SMA:** 195.29
*   **60-day SMA:** 195.47

The price has recently declined, and is trading below its 5-day SMA and the negative change shows a downward pressure.

**3) RSI, PPO and Other Indicators:**

*   **Market Risk Indicator (MRI):** 0.9 (High Investment Recommended).  *This seems contradictory given the other data. The MRI alone suggests a favorable investment environment, but should be treated with care in conjunction with other indicators*
*   **RSI:** 58.05.  This is in neutral territory (typically, above 70 is overbought, below 30 is oversold), suggesting neither strong buying nor selling pressure.
*   **PPO:** 0.02. This is around zero, shows weak momentun.
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (1 shares - Safe - MRI:0.80) (Cash Ratio: 0% on 2025-12-04).
*   **Recent (20 days) relative divergence change:** 1.4 (+): 단기상승 (Short-term increase). A positive change suggests Honeywell is slightly improving relative to the S&P 500 in the short term.
*   **Price Change:** The price change indicates a small downward fluctuation.
*   **Expected Return (%):** 0.0.  The model predicts no excess return compared to the S&P 500 for a long-term investment *from this point*.

**4) Recent News & Significant Events:**

*   **Pentagon Contract Modification:** A $58.8 million Army contract modification could have a minor impact.
*   **Indra Nooyi Joins Board:**  This could be viewed positively, bringing expertise and potentially influencing strategic decisions.
*   **Meyer Handelman Co. Reduced Holdings:** This could be a negative signal, but it depends on the size of the reduction and the reasons behind it.
*   **HON vs. 3M Comparison:** The relative strength against a peer is important.
*   **Honeywell Stock Signal:** "Time to Go Long?"  This is a bullish signal from one source, but needs to be considered with all other data.
*   **Potential Settlement:** A potential $470M settlement is a significantly negative event that would affect earnings.

**4-2) Analyst Opinions:**

*   **Consensus:** Buy (2.07 on scale, 24 opinions).  This is a generally positive outlook.
*   **Target Price:** Average target price is 236.61, significantly higher than the current price. This suggests analysts believe the stock is undervalued.
*   **Recent Rating Changes:** No recent rating changes are listed. This lack of activity doesn't necessarily mean anything, but it's worth noting.

**5) Recent Earnings Analysis:**

| Date       | EPS  | Revenue      |
|------------|------|--------------|
| 2025-10-23 | 2.87 | 10.41 B$     |
| 2025-07-24 | 2.46 | 10.35 B$     |
| 2025-04-29 | 2.24 | 9.82 B$      |
| 2024-10-24 | 2.17 | 9.73 B$      |
| 2025-10-23 | 2.17 | 9.73 B$      |

*   **EPS (Earnings Per Share):** EPS has been increasing over the past few quarters, a positive sign. However, the last two entries on the table appear to be duplicates.
*   **Revenue:** Revenue has also been generally increasing.

**6) Financial Information:**

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
|--------------|------------|---------------|
| 2025-09-30   | $10.41B    | 34.08%        |
| 2025-06-30   | $10.35B    | 38.86%        |
| 2025-03-31   | $9.82B     | 38.54%        |
| 2024-12-31   | $10.09B    | 36.38%        |
| 2024-09-30   | $9.73B     | 38.54%        |

*   **Revenue:** Consistent revenue growth is visible.
*   **Profit Margin:** The profit margin is quite good and also showing fluctuations.

**Capital and Profitability:**

| Quarter      | Equity      | ROE     |
|--------------|-------------|---------|
| 2025-09-30   | $16.78B     | 10.87%  |
| 2025-06-30   | $16.09B     | 9.75%   |
| 2025-03-31   | $17.46B     | 8.30%   |
| 2024-12-31   | $18.62B     | 6.90%   |
| 2024-09-30   | $17.41B     | 8.12%   |

*   **Equity:** Equity has fluctuated somewhat.
*   **ROE (Return on Equity):** ROE has been increasing which is a positive sign.

**7) Comprehensive Analysis:**

*   **Underperformance:** HON has significantly underperformed the S&P 500, with a large negative divergence.
*   **Declining Alpha:** The negative Alpha values highlight the stock's recent inability to generate excess returns compared to the market.
*   **High Volatility:** The high Maximum Drawdown (MDD) values indicate significant price volatility.
*   **Mixed Signals:** While analyst consensus is generally positive with a "Buy" rating and a significantly higher target price, the technical indicators (RSI, PPO) and recent stock price movements provide mixed signals. The MRI indicates high investment recommendation, which appears contrarian.
*   **Earnings Growth:** EPS and revenue have been generally increasing, which is a positive factor.
*   **Potential Headwinds:** The potential $470M settlement and Meyer Handelman Co. reducing holdings introduce uncertainty.
*   **Recent Events:** Indra Nooyi's joining the board is a positive development.
*   **Financial Health:** The ROE is increasing and the profit margin is high.

**Overall Conclusion:**

Honeywell presents a mixed picture. While the company shows earnings growth and has positive analyst ratings, its significant underperformance compared to the S&P 500, declining Alpha, high volatility, and a potential large settlement raise concerns. The MRI indicator contradicts most of the other data and should be cautiously reviewed. Any investment decision should carefully weigh these factors and consider your individual risk tolerance.  Further investigation into the reasons for the underperformance and the details of the potential settlement are warranted. The short-term increase in relative divergence and the analyst target prices suggest some potential upside, but these must be balanced against the longer-term trends.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.